Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS)
about
Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS)
description
scientific article published on 11 September 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2018
@uk
name
Study protocol for the MEXilet ...... ar muscular atrophy (MEXPRESS)
@en
Study protocol for the MEXilet ...... ar muscular atrophy (MEXPRESS)
@nl
type
label
Study protocol for the MEXilet ...... ar muscular atrophy (MEXPRESS)
@en
Study protocol for the MEXilet ...... ar muscular atrophy (MEXPRESS)
@nl
prefLabel
Study protocol for the MEXilet ...... ar muscular atrophy (MEXPRESS)
@en
Study protocol for the MEXilet ...... ar muscular atrophy (MEXPRESS)
@nl
P2093
P2860
P50
P1433
P1476
Study protocol for the MEXilet ...... ar muscular atrophy (MEXPRESS)
@en
P2093
Akihiro Hirakawa
Atsushi Hashizume
Daisuke Ito
Fumie Kinoshita
Shinichiro Yamada
Tomohiko Nakamura
Yumiko Kobayashi
P2860
P304
P356
10.1136/BMJOPEN-2018-023041
P407
P577
2018-09-11T00:00:00Z